Echinocystic acid alleviated hypoxic-ischemic brain damage in neonatal mice by activating the PI3K/Akt/Nrf2 signaling pathway

Abstract

Neonatal hypoxic-ischemic encephalopathy (HIE) is considered a major cause of death and long-term neurological injury in newborns. Studies have demonstrated that oxidative stress and apoptosis play a major role in the progression of neonatal HIE. Echinocystic acid (EA), a natural plant extract, shows great antioxidant and antiapoptotic activities in various diseases. However, it has not yet been reported whether EA exerts a neuroprotective effect against neonatal HIE. Therefore, this study was undertaken to explore the neuroprotective effects and potential mechanisms of EA in neonatal HIE using in vivo and in vitro experiments. In the in vivo study, a hypoxic-ischemic brain damage (HIBD) model was established in neonatal mice, and EA was administered immediately after HIBD. Cerebral infarction, brain atrophy and long-term neurobehavioral deficits were measured. Hematoxylin and eosin (H&E), terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and dihydroethidium (DHE) staining were performed, and the contents of malondialdehyde (MDA) and glutathione (GSH) were detected. In the in vitro study, an oxygen-glucose deprivation/reperfusion (OGD/R) model was employed in primary cortical neurons, and EA was introduced during OGD/R. Cell death and cellular ROS levels were determined. To illustrate the mechanism, the PI3K inhibitor LY294002 and Nrf2 inhibitor ML385 were used. The protein expression levels of p-PI3K, PI3K, p-Akt, Akt, Nrf2, NQO1, and HO-1 were measured by western blotting. The results showed that EA treatment significantly reduced cerebral infarction, attenuated neuronal injury, and improved brain atrophy and long-term neurobehavioral deficits in neonatal mice subjected to HIBD. Meanwhile, EA effectively increased the survival rate in neurons exposed to OGD/R and inhibited oxidative stress and apoptosis in both in vivo and in vitro studies. Moreover, EA activated the PI3K/Akt/Nrf2 pathway in neonatal mice following HIBD and in neurons after OGD/R. In conclusion, these results suggested that EA alleviated HIBD by ameliorating oxidative stress and apoptosis via activation of the PI3K/Akt/Nrf2 signaling pathway.

Fecal microbiota transplantation from HUC-MSC-treated mice alleviates acute lung injury in mice through anti-inflammation and gut microbiota modulation

“…In addition, the Nrf2/HO-1 pathway is also a crucial pathway for antioxidant defense (Su et al, 2020 ). Following oxidative stress, Nrf2 separates from Keap-1, combines with the antioxidant response element (ARE), and then elevates the expression of some antioxidant-encoding proteins, which protect against oxidative stress in ALI (Li Y. et al, 2023 ). Bi et al have revealed that activating the Nrf2/HO-1 pathway can reduce oxidative stress in ALI mice.…”

Mas receptor activation facilitates innate hematoma resolution and neurological recovery after hemorrhagic stroke in mice

“…Previous studies have found that phosphorylation of Akt had the ability to reduce cellular apoptosis and ease neuroinflammation in diverse pathophysiological conditions [ 47 – 49 ]. On the other hand, Akt signaling has been reported to regulate the Nrf2 transcription factors, which aid in suppressing oxidative stress and negatively modulating the inflammatory response [ 27 – 29 , 50 ]. Numerous studies have indicated that Nrf2 contributed to modulating the functional phenotype of microglia and enhancing microglial phagocytosis in brain injury [ 26 , 51 – 54 ].…”

Impact of NQO1 dysregulation in CNS disorders

“…The activation of the PI3K/Akt signaling also promotes the detachment of Nrf2 from KEAP1, facilitates its translocation to the nucleus, and regulates Nrf2 activation in a ROS-dependent manner [ 106 , 107 ]. The induction of the PI3K/Akt/Nrf2 signaling axis ameliorates oxidative stress and apoptosis via the regulation of Nrf2, NQO1, and HO-1 [ 108 ].…”